These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16440261)
21. Immunomodulation in sepsis: state of the art and future perspective. Antonopoulou A; Giamarellos-Bourboulis EJ Immunotherapy; 2011 Jan; 3(1):117-28. PubMed ID: 21174562 [TBL] [Abstract][Full Text] [Related]
22. Current trends in the research on antiinflammatory agents. Bertelli A; Silvestrini B Int J Tissue React; 1985; 7(3):169-73. PubMed ID: 3899967 [TBL] [Abstract][Full Text] [Related]
23. What is sepsis, and why is it life threatening? Rosen DS Health News; 2001 Apr; 7(4):10. PubMed ID: 11303476 [No Abstract] [Full Text] [Related]
25. Is there a treatment for sepsis other than antibiotics? Paul M Clin Microbiol Infect; 2009 Apr; 15(4):297. PubMed ID: 19416299 [No Abstract] [Full Text] [Related]
27. [Controlled double blind studs f the effective useflness of a nepical drug in the treatment o inflammation of the upper respiratory tract]. Cordone G; Calvari E Otorinolaringol Ital; 1969 Aug; 37(5):365-74. PubMed ID: 5399754 [No Abstract] [Full Text] [Related]
28. Activated protein C--an anticoagulant that does more than stop clots. Jackson CJ; Xue M Int J Biochem Cell Biol; 2008; 40(12):2692-7. PubMed ID: 18249579 [TBL] [Abstract][Full Text] [Related]
29. Modulation of sepsis outcome with variants of activated protein C. Weiler H; Kerschen E J Thromb Haemost; 2009 Jul; 7 Suppl 1():127-31. PubMed ID: 19630784 [TBL] [Abstract][Full Text] [Related]
30. [Application of recombinant human activated protein C with blood product administration and deep vein thrombosis in severe sepsis]. Liu L; Guo FM; Qiu HB Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Nov; 16(11):643-5. PubMed ID: 15535893 [No Abstract] [Full Text] [Related]
31. [Possibility of non-steroid anti-inflammatory drugs as a substitute for steroids--analysis of the present situation and demands for the future]. Mizushima Y Nihon Rinsho; 1968 Jan; 26(1):61-5. PubMed ID: 5748535 [No Abstract] [Full Text] [Related]
32. Corticosteroids in the ICU. Abdel-Moez W; Kolla J; Omar H; Mangar D; Camporesi EM Int Anesthesiol Clin; 2009; 47(1):67-82. PubMed ID: 19131753 [No Abstract] [Full Text] [Related]
33. Severe sepsis in a premature neonate: protein C replacement therapy. De Carolis MP; Polimeni V; Papacci P; Lacerenza S; Romagnoli C Turk J Pediatr; 2008; 50(4):405-8. PubMed ID: 19014060 [TBL] [Abstract][Full Text] [Related]
34. Clinical expert round table discussion (session 5) at the Margaux Conference on Critical Illness: outcomes of clinical trials in sepsis: lessons learned. Vincent JL; Angus D; Annane D; Bernard G; Faist E; Giroir B; Reinhart K Crit Care Med; 2001 Jul; 29(7 Suppl):S136-7. PubMed ID: 11445749 [No Abstract] [Full Text] [Related]
35. The definition of septic shock: implications for treatment. Marik PE; Lipman J Crit Care Resusc; 2007 Mar; 9(1):101-3. PubMed ID: 17352674 [TBL] [Abstract][Full Text] [Related]
37. Severe sepsis and septic shock in the emergency department. Talan DA; Moran GJ; Abrahamian FM Infect Dis Clin North Am; 2008 Mar; 22(1):1-31, v. PubMed ID: 18295681 [TBL] [Abstract][Full Text] [Related]
38. The current management of septic shock. Russel JA Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911 [TBL] [Abstract][Full Text] [Related]
39. Signal transduction induced by activated protein C: no role in protection against sepsis? Slofstra SH; ten Cate H; Spek CA Trends Mol Med; 2006 Aug; 12(8):374-81. PubMed ID: 16820322 [TBL] [Abstract][Full Text] [Related]
40. [Antithrombin III in the treatment of sepsis-- new approaches to prescribing the old drug]. Galstian GM; Shutova NA; Gorodetskiĭ VM Anesteziol Reanimatol; 2007; (6):66-71. PubMed ID: 18326265 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]